Is Canopy Growth Stock a Buy in December 2022?

Canopy Growth stock climbed 80% before falling back once more. So should you jump on an opportunity, or be fearful of another drop?

| More on:
Cannabis grows at a commercial farm.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth (TSX:WEED) has received some attention over the last few months, with a few headlines bringing the share price higher. In fact, shares soared by 80% between October and November, before falling back.

Even after the climb, shares of Canopy Growth stock are still down by about 70% year to date. That’s even more when you consider all-time highs. Yet with all this renewed attention to the industry, is Canopy Growth stock a buy in December 2022?

What’s been happening

In October, headlines started exploding when President Joe Biden stated he would pardon those who received a criminal charge for simple marijuana possession, and urged states to do the same. This was a major step towards what the administration hoped to achieve on election: marijuana decriminalization.

This positive sign looked like enough for Canopy Growth stock to move forward with its plan for United States domination. The company announced it would go through with its 100% ownership of Acreage, expanding its U.S. operations significantly.

This caused the share spike we saw back in October. Yet, then shares dropped back once again. So what happened?

Oh, right, earnings

While it was great to see the company move forward with the Acreage plan, it still didn’t solve the earnings problem. Canopy Growth stock has been chipping away at its losses, which are significant. It has closed operations, and focused on its non-marijuana business ventures, such as BioSteel, to move towards profitability.

This has been the main focus of the last few years, but it’s still a work in progress. During the most recent earnings report, Canopy Growth stock announced revenue growth of 7% year over year, with a 299% net revenue increase from BioSteel. The company also divested some Canadian retail operations, to bring in $70 to $100 million in savings. The loss now stands at $232 million.

What investors should think

Canopy Growth stock has been improving its debt. The new Acreage operations will also certainly help bring in cash flow. Further, more states than ever plan to allow the recreational use of cannabis. However, there is still more work to be done.

As we head into a potential recession, it could very well be that Canopy Growth stock gets worse before it gets better. If you’re willing to wait a while (and I do mean a while), then by all means get into the cannabis industry. It’s set to continue climbing, and Canopy Growth stock could honestly end up being the biggest cannabis producer in the world over the next decade.

However, that doesn’t mean there would not be risks along the way. And I’ll be honest, I do not think you should sink a bunch of cash into this stock. It’s far too risky, and should an emergency come up where you need the dough, you could be out of luck.

So, bottom line, Canopy Growth stock is a great opportunity if you’re looking for a small stake you could drip feed into. However, if you think it’s about to get you rich in the months to come, I’d certainly think again.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »